FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide (TM))

S. Belikov, C. Oberg, Tiina Jääskeläinen, V. Rahkama, J. J. Palvimo, O. Wrange

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalMolecular and Cellular Endocrinology
Volume365
Issue number1
Pages (from-to)95-107
Number of pages13
ISSN0303-7207
DOIs
Publication statusPublished - 5 Jan 2013
Externally publishedYes
MoE publication typeA1 Journal article-refereed

Fields of Science

  • FoxA1
  • Androgen receptor
  • Xenopus oocyte
  • Chromatin presetting
  • Bicalutamide
  • MDV3100 (Enzalutamide)
  • GLUCOCORTICOID-RECEPTOR BINDING
  • RESISTANT PROSTATE-CANCER
  • ANDROGEN-RECEPTOR
  • IN-VIVO
  • CHROMATIN-STRUCTURE
  • MMTV PROMOTER
  • TRANSCRIPTIONAL REGULATION
  • DNA-BINDING
  • ACETYLATION
  • EXPRESSION

Cite this